EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A NIR‐II Photoactivatable “ROS Bomb” with High‐Density Cu 2 O‐Supported MoS 2 Nanoflowers for Anticancer Therapy

Jia Huang, Guiming Deng, Shuya Wang, Tianjiao Zhao, Qiaohui Chen, Yuqi Yang, Yongqi Yang, Jinping Zhang, Yayun Nan, Zhaoqian Liu, Ke Cao, Qiong Huang und 1 weitere

Advanced Science · 2023

DOI: 10.1002/advs.202302208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Jia Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, China. Hauptthemen laut MEDLINE: Copper, Molybdenum. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hunan Science Fund for Distinguished Young Scholar of China, Hunan Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The fast conversion of hydrogen peroxide (H 2 O 2 ) into reactive oxygen species (ROS) at tumor sites is a promising anticancer strategy by manipulating nanomedicines with near‐infrared light in the second region (NIR‐II). However, this strategy is greatly compromised by the powerful antioxidant capacity of tumors and the limited ROS generation rate of nanomedicines. This dilemma mainly stems from the lack of an effective synthesis method to support high‐density copper‐based nanocatalysts on the surface of photothermal nanomaterials. Herein, a multifunctional nanoplatform (MCPQZ) with high–density cuprous (Cu 2 O) supported molybdenum disulfide (MoS 2 ) nanoflowers (MC NFs) is developed for the efficient killing of tumors via a potent ROS storm by an innovative method. Under NIR‐II light irradiation, the ROS intensity and maximum reaction velocity ( V max ) produced by MC NFs are 21.6 and 33.8 times that of the non–irradiation group in vitro, which is much higher than most current nanomedicines. Moreover, the strong ROS storm in cancer cells is efficiently formed by MCPQZ (increased by 27.8 times compared to the control), thanks to the fact that MCPQZ effectively pre–weakens the multiple antioxidant systems of cancer cells. This work provides a novel insight to solve the bottleneck of ROS‐based cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperMolybdenumReactive Oxygen SpeciesPhototherapyAntioxidantsCell Line, Tumor

Stichwörter der Autor:innen

chemodynamic therapycuprous oxidemolybdenum disulfidephotothermal therapysynergistic therapy

Substanzen

Reactive Oxygen SpeciesCopperMolybdenumAntioxidants

Autor:innen und Institutionen

  • Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410078, China.
  • Hunan Provincial Key Laboratory of Cardiovascular Research, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410078, China.
  • Department of infection and liver disease, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Geriatric Medical Center, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, 750002, China.

ORCID-Profile: Kelong Ai

Förderung

  • National Natural Science Foundation of China
  • Hunan Science Fund for Distinguished Young Scholar of China
  • Hunan Provincial Natural Science Foundation of China
  • Central South University Research Programme of Advanced Interdisciplinary Studies
  • Key Research Project of Ningxia Hui Autonomous Region in 2021 of China
  • Key Program of Ningxia Hui Autonomous Region Natural Science Foundation of China

Zitieren

APA

Huang, J., Deng, G., Wang, S., Zhao, T., Chen, Q., Yang, Y., Yang, Y., Zhang, J., Nan, Y., Liu, Z., Cao, K., Huang, Q., & Ai, K. (2023). A NIR‐II Photoactivatable “ROS Bomb” with High‐Density Cu 2 O‐Supported MoS 2 Nanoflowers for Anticancer Therapy. Advanced Science. https://doi.org/10.1002/advs.202302208

Vancouver

Huang J, Deng G, Wang S, Zhao T, Chen Q, Yang Y, et al. A NIR‐II Photoactivatable “ROS Bomb” with High‐Density Cu 2 O‐Supported MoS 2 Nanoflowers for Anticancer Therapy. Advanced Science. 2023. doi:10.1002/advs.202302208

BibTeX
@article{Huang2023,
  author = {Huang, Jia and Deng, Guiming and Wang, Shuya and Zhao, Tianjiao and Chen, Qiaohui and Yang, Yuqi and Yang, Yongqi and Zhang, Jinping and Nan, Yayun and Liu, Zhaoqian and Cao, Ke and Huang, Qiong and Ai, Kelong},
  title = {A NIR‐II Photoactivatable “ROS Bomb” with High‐Density Cu 2 O‐Supported MoS 2 Nanoflowers for Anticancer Therapy},
  journal = {Advanced Science},
  year = {2023},
  doi = {10.1002/advs.202302208}
}
Kostenlos starten →